Clin2
NCT07128394Possibly a fitRecruiting

Extra LH hormone for better embryos in IVF with low LH

Infertility, FemaleLuteinizing Hormone (LH)

Part of Women’s health & pregnancy clinical trials.

This trial tests whether giving extra luteinizing hormone (LH) can improve embryo quality in women with very low LH levels during IVF. It may help you if you have low LH and are using a specific type of fertility medication.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
590 people
Ages
20 years to 37 years
Study type
Interventional

Who can take part

  • You are between 20 and 37 years old.
  • You are undergoing IVF or ICSI with a long-acting GnRH agonist protocol.
  • Your LH level is very low (less than 0.5 U/L) after the start of treatment.
  • You have a normal uterine cavity (checked by a special exam within the last 6 months).
  • You do not have PCOS, endometriosis, or a history of ovarian surgery.
  • You have a good egg reserve (more than 5 antral follicles, AMH above 1.1 ng/mL, and FSH not above 10 IU/L).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07108621Recruiting· Phase 3
HCG priming before IVF for low egg reserve

This trial tests whether giving a hormone called hCG before starting IVF can improve outcomes for women with low egg reserve (low AMH). It is designed for women under 40 who are early in their IVF journey.

Copenhagen
NCT07346235Not yet recruiting· Phase 3
Comparing two doses of fertility medication for IVF

This trial compares two doses of follicle-stimulating hormone (FSH) to find out which dose helps women with normal ovarian reserve have better IVF outcomes. It aims to improve the chances of a successful pregnancy.

Pristina
NCT06006091Recruiting
Letrozole for preparing the womb before embryo transfer

This study tests if a medicine called letrozole can help prepare the lining of the womb for a frozen embryo transfer. It may be an option for women under 40 who have had limited previous IVF cycles.

Shanghai
NCT06571214Not yet recruiting· Phase 4
Adding a hormone to IVF treatment for women aged 35 to 40

This study tests whether adding a hormone called r-hLH to standard IVF treatment helps women aged 35 to 40 produce better eggs and improve their chances of pregnancy. It is for women who are on their first or second cycle of assisted reproduction.

Nanjing, Jiangsu
NCT06883890Not yet recruiting· Phase 2
Extended LH for women with low LH in ivf

This study tests whether giving an extra hormone called LH before egg retrieval helps improve IVF outcomes for women with naturally low LH levels. If you qualify, you may receive this added hormone to see if it helps your eggs mature better.

NCT04719000Recruiting· Phase 4
Personalized LH addition during IVF to improve egg growth

This trial tests whether adding a personalized amount of “LH” during IVF hormone stimulation can help your ovaries respond better. It may be useful if you’ve had a weaker IVF response before and fit specific age and egg-quality markers.

Barcelona

Hear when a new Infertility, Female trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.